Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 3/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.77 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.77 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.77 |
| ▸ | OSBP | P22059 | 5/20 | 0.75 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.75 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.75 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.75 |
| ▸ | DHCR24 | Q15392 | 1/20 | 0.74 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.74 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.73 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Desmosterol SCHEMBL26641636 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL12917612 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL156561 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL18942512 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL13833045 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL288290 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL23565992 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL2154711 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL288400 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP | |
| Desmosterol SCHEMBL19507013 | 1.00 | RORC (1.00) | RORCGRIN1GRIN2AGRIN2BOSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3236927-A1 | HAIR COMPOSITION | Unilever PLC (GB) | 2017-11-01 | — | — | EP | claimed |
| WO-2016102177-A1 | HAIR COMPOSITION | UNILEVER PLC (GB) | 2016-06-30 | — | — | WO | claimed |
| EP-2788088-A1 | SKIN ANTI-AGEING COMPOSITION | Unilever Plc. (GB) | 2014-10-15 | — | — | EP | claimed |
| WO-2013083431-A1 | SKIN ANTI-AGEING COMPOSITION | UNILEVER PLC (GB) | 2013-06-13 | — | — | WO | claimed |
| CN-114467578-A | Method for preventing and treating plant nematodes | 海南大学 | 2022-05-13 | — | — | CN | disclosed |
| US-11313866-B2 | Method of diagnosing and treating asphyxia | INFANDX AG (DE) | 2022-04-26 | — | — | US | disclosed |
| EP-2249161-B1 | Method of diagnosing asphyxia | INFANDX AG (DE) | 2020-05-13 | — | — | EP | disclosed |
| EP-2829607-B1 | GENE ENCODING OF ENZYME FOR REDUCING POSITION 24 OF STEROID SKELETON AND PLANT HAVING REDUCED EXPRESSION OF SAME GENE | KIRIN HOLDINGS KK (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-10308971-B2 | Microorganism for expressing a human membrane protein | NOVOZYMES A/S (DK) | 2019-06-04 | — | — | US | disclosed |
| US-20180171374-A1 | Microorganism For Expressing A Human Membrane Protein | NOVOZYMES A/S (DK) | 2018-06-21 | — | — | US | disclosed |
| US-9920348-B2 | Microorganism for expressing a human membrane protein | NOVOZYMES A/S (DK) | 2018-03-20 | — | — | US | disclosed |
| US-20180011111-A1 | Method of Diagnosing and Treating Asphyxia | INFANDX AG (DE) | 2018-01-11 | — | — | US | disclosed |
| EP-2249161-A1 | Method of diagnosing asphyxia | BIOCRATES Life Sciences AG (AT) | 2010-11-10 | — | — | EP | disclosed |
| US-20100063272-A1 | METHOD FOR PRODUCING STEROID COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20090239837-A1 | CHOLESTEROL-PRODUCING YEAST STRAINS AND USES THEREOF | AVENTIS PHARMA S.A. (FR) | 2009-09-24 | — | — | US | disclosed |
| EP-1985621-A1 | PROCESS FOR PRODUCTION OF STEROIDS | Mitsubishi Chemical Corporation (JP) | 2008-10-29 | — | — | EP | disclosed |
| EP-1775304-A1 | PROCESS FOR PRODUCTION OF STEROIDS | Mitsubishi Chemical Corporation (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-20060252948-A1 | Production method of steroid compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-11-09 | — | — | US | disclosed |
| EP-0958370-A1 | TRANSGENIC PLANTS WITH MODIFIED STEROL BIOSYNTHETIC PATHWAYS | MONSANTO COMPANY (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1998045457-A1 | TRANSGENIC PLANTS WITH MODIFIED STEROL BIOSYNTHETIC PATHWAYS | MONSANTO COMPANY (US) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252948-A1 | Production method of steroid compound | CYP46A1, DHCR7, CYP51A1 | RORC 265/4885GRIN1 4522/4885GRIN2A 3422/4885 |
| US-20100063272-A1 | METHOD FOR PRODUCING STEROID COMPOUND | CYP46A1, DHCR7, HSD17B7 | RORC 305/4885GRIN1 4157/4885GRIN2A 3267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.